FPS
IONS icon

Fieldpoint Private Securities’s Ionis Pharmaceuticals IONS Stock Holding History

Fieldpoint Private Securities’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,288
Closed -$65K – 477
2017
Q3 		$65K Buy
+1,288
New +$67.5K 0.03% 345

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fieldpoint Private Securities's IONS Position: Q4 2017 in Review

Fieldpoint Private Securities sold out of Ionis Pharmaceuticals (IONS) in Q4 2017, closing a stake of 1,288 shares — an estimated $65K sold.

Fieldpoint Private Securities first reported a position in IONS in Q3 2017 and held it in 1 quarter. The position peaked at $65K in Q3 2017. 316 funds tracked by Wall St. Rank hold IONS as of Q4 2017.

  • Fieldpoint Private Securities reported no remaining Ionis Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Fieldpoint Private Securities sold 1,288 Ionis Pharmaceuticals shares in Q4 2017, an estimated $65K.
  • Fieldpoint Private Securities first reported a position in Ionis Pharmaceuticals in Q3 2017 and held it in 1 quarter.
  • Fieldpoint Private Securities's Ionis Pharmaceuticals position peaked at $65K in Q3 2017.
  • 316 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2017.

Based on Fieldpoint Private Securities's 13F filing for Q4 2017, filed 15 Feb 2018.